Pepdox
Studies
Peptides
Calculator
Home
/
Search
/
PMID 38956439
A pre-specified analysis of the SELECT trial suggests a kidney benefit of semaglutide in patients without diabetes.
Nature reviews. Nephrology
2024
PMID: 38956439
View on PubMed
DOI: 10.1038/s41581-024-00865-7
Semaglutide
Authors
Carney, Ellen F
A pre-specified analysis of the SELECT trial suggests a kidney benefit of semaglutide in patients without diabetes. | Pepdox